Find trials
Search tips

Epidemiology of Chronic Lymphocytic Leukemia

Overview

About this study

The overall goals of this study are to evaluate similarities and differences of the known genetic and non-genetic epidemiological factors associated with chronic lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patient identified as having CLL or MBL, precursor condition to CLL and over the age of 18

Exclusion Criteria: 

  • No diagnosis of CLL or MBL

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Susan Slager, Ph.D.

Open for enrollment

Contact information:

Catherine Erding

(507) 284-5522

Erding.Catherine@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20531057

Mayo Clinic Footer